News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA to Review Arcoxia, Merck & Co., Inc. (MRK)'s (Jobs) Follow-Up to Vioxx


3/5/2007 10:53:54 AM

A Food and Drug Administration panel in April will review Merck's Arcoxia, its follow-up to the controversial painkiller Vioxx, which was pulled from the market in 2004 following safety concerns.

>>> Discuss This Story


Read at AP
Read at Philadelphia Inquirer


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES